BioCentury | Nov 11, 2016
Company News

HEC, TaiGen deal NS5A inhibitor . TaiGen will contribute its Greater China rights to furaprevir ( TG-2349...
...Pharm Group , Dongguan, China TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157), Taipei, Taiwan Business: Infectious Nora Weintraub DAG-181 NS5A inhibitor TG-2349 HEC...
BioCentury | Oct 31, 2016
Company News

TaiGen, HEC launch cross-strait newco for HCV combo

...and TaiGen will contribute its Greater China rights to HCV protease inhibitor furaprevir ( TG-2349...
BioCentury | Apr 26, 2016
Politics & Policy

CFDA names HCV drugs in expedited pathway

...Exviera dasabuvir from AbbVie Inc. (NYSE:ABBV); Olysio simeprevir from Johnson & Johnson (NYSE:JNJ); furaprevir ( TG-2349...
BioCentury | Aug 3, 2015

Taiwan's post-bubble prognosis

...experienced investors coming in." In addition to Taigexyn and burixafor, TaiGen is developing furaprevir ( TG-2349...
Items per page:
1 - 4 of 4